C12N5/0043

Corn active peptide additive for cell culture medium

The present invention provides a corn active peptide additive for cell culture medium, wherein in the corn active peptide additive, oligopeptides with molecular weight of lower than 1000 Dalton account for equal to or more than 90 wt % of total proteins, and the oligopeptides at least comprise one or more of AP, SAP, PAL, VNAP, PSSQ, and TQPGPQ. The corn active peptide additive of the present invention can be compounded with various basic culture mediums for serum-free culture of various animal cells, which not only substantially lowers the cost for cell culturing and reduces pollution and other problems caused by an animal derived component, but also can promote cell proliferation, improve cell viability and enhance expression of cell products.

PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIA

The present invention relates generally to glutamine-free cell culture media supplemented with asparagine. The invention further concerns the production of recombinant proteins, such as antibodies, in asparagine-supplemented glutamine-free mammalian cell culture.

PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIA

The present invention relates generally to glutamine-free cell culture media supplemented with arginine. The invention further concerns the production of recombinant proteins, such as antibodies, in arginine-supplemented glutamine-free mammalian cell culture.

Serum-free cell culture medium

The specification describes an improved serum-free animal cell culture medium, which can used for the production of a protein of interest. Ornithine, or a combination of ornithine and putrescine can be added to serum-free media or chemically defined media to improve viable cell density, to reduce cell doubling time, and to increase the production of a protein of interest.

Production of proteins in glutamine-free cell culture media

The present invention relates generally to glutamine-free cell culture media supplemented with arginine. The invention further concerns the production of recombinant proteins, such as therapeutic IgG antibodies, in a Chinese hamster ovary (CHO) host cell in a production phase culture medium that is essentially free of glutamine and comprises arginine in arginine.

CELL CULTURE MEDIA CONTAINING COMBINATIONS OF PROTEINS

The present invention relates to methods of culturing cells and achieving an improved growth rate of cultured cells and/or a higher productivity of the cultured cells, in cell culture media supplemented with recombinant plant-produced growth factors and/or interleukins, and supplements and kits therefor.

System and Method for Improved Transient Protein Expression in CHO Cells
20250263770 · 2025-08-21 ·

The present invention is directed generally to systems and methods suitable for high level expression of recombinant proteins in suspension CHO cells. In particular, the invention allows introduction of the invention obviates the need to replace, replenish or supplement the growth medium during the procedure. The invention also relates to compositions and kits useful for culturing and transforming/transfecting suspension CHO cells.

Media for culturing stem cells

Well-defined, xeno-free culture media which comprise a TGF-beta isoform or the chimera formed between IL6 and the soluble IL6 receptor (IL6RIL6), which are capable of maintaining stem cells, and particularly, human embryonic stem cells, in an undifferentiated state are provided. Also provided are cell cultures comprising the culture media and the stem cells and methods of expanding and deriving embryonic stem cells in such well-defined, xeno-free culture media. In addition, the present invention provides methods of differentiating ESCs or EBs formed therefrom for the generation of lineage specific cells.

Methods of culturing a mammalian cell

Provided herein are methods of culturing a mammalian cell in a liquid medium including poloxamer-188 at a concentration of 1.8 g/L or at a greater concentration than 1.8 g/L more or a liquid medium that includes a poloxamer-188 concentration that is selected based on one or more factors selected from the group of: pore size, pore type, gas flow rate, viable cell density in the medium, and markers related to cell stress.

CULTIVATED ANIMAL CELLS ADAPTED FOR GROWTH IN LOW AMOUNTS, AND/OR THE ABSENCE OF, DIRECT GROWTH FACTORS, INDIRECT GROWTH FACTORS, ANIMAL SERUM, AND/OR ANIMAL COMPONENTS, AND METHODS OF USE THEREOF

Provided herein are cultivated animal cells that are adapted to grow in growth medium that contains low-insulin or no exogenously provided insulin. Provided herein are cultivated animal cells that are adapted to grow in growth medium that contains low-transferrin or no exogenously provided transferrin. Provided herein are methods of cultivating animal cells in growth medium that contains low-insulin or no exogenously provided insulin. Provided herein are methods of cultivating animal cell in growth medium that contains low-transferrin or no exogenously provided transferrin. Also provided are food products made from cultivated animal cells.